{"id":320,"date":"2019-03-15T16:00:35","date_gmt":"2019-03-15T07:00:35","guid":{"rendered":"https:\/\/info.zanet.biz\/?p=320"},"modified":"2019-04-02T18:51:19","modified_gmt":"2019-04-02T09:51:19","slug":"cea-alongside-clinical-trials-ii","status":"publish","type":"post","link":"https:\/\/info.zanet.biz\/?p=320","title":{"rendered":"CEA alongside clinical trials II"},"content":{"rendered":"\n

\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u6642\u306b\u533b\u7642\u7d4c\u6e08\u7684\u5206\u6790\u3092\u81e8\u5e8a\u8a66\u9a13\u306b\u542b\u3081\u3066\u884c\u3046\u5834\u5408\u306e\u30ac\u30a4\u30c0\u30f3\u30b9\u304c International Society for Pharmacoeconomics and Outcomes Research (ISPOR<\/a>)\u00a0\u56fd\u969b\u533b\u85ac\u7d4c\u6e08\u30fb\u30a2\u30a6\u30c8\u30ab\u30e0\u7814\u7a76\u5b66\u4f1a \u3088\u308a2014\u5e74\u306b\u767a\u8868\u3055\u308c\u3066\u3044\u308b\u3002 Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD: Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health 2015;18:161-72. PMID: 25773551<\/a> <\/p>\n\n\n\n

\u3053\u308c\u306f2005\u5e74\u306b\u767a\u8868\u3055\u308c\u305f\u5831\u544a\u306e\u6539\u8a02\u7248\u3067\u3042\u308b\u3002\u6284\u9332\u304b\u3089\u629c\u7c8b\u3059\u308b\u3068\uff1a\u201d \u81e8\u5e8a\u8a66\u9a13\u306e\u30c7\u30b6\u30a4\u30f3\u3001\u30c7\u30fc\u30bf\u8981\u7d20\u306e\u9078\u629e\u3001\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u30c7\u30b6\u30a4\u30f3\u3068\u7ba1\u7406\u3001\u5206\u6790\u3001\u7d50\u679c\u306e\u5831\u544a\u306b\u3064\u3044\u3066\u306e\u63a8\u5968\u30922014\u5e74\u306b\u6539\u8a02\u3057\u305f\u3002\u81e8\u5e8a\u8a66\u9a13\u306fEfficacy\u3067\u306f\u306a\u304fEffectiveness\u3092\u8a55\u4fa1\u3057\u3001\u81e8\u5e8a\u7684\u30a2\u30a6\u30c8\u30ab\u30e0\u306e\u6e2c\u5b9a\u3092\u542b\u3080\u3079\u304d\u3067\u3042\u308a\u3001\u7814\u7a76\u5bfe\u8c61\u8005\u304b\u3089\u533b\u7642\u8cc7\u6e90\u306e\u5229\u7528\u3068\u5065\u5eb7\u72b6\u614b\u52b9\u7528\u5024health state utilities\u3092\u76f4\u63a5\u5f97\u308b\u3079\u304d\u3067\u3042\u308b\u3002\u7d4c\u6e08\u7684\u30c7\u30fc\u30bf\u306e\u53ce\u96c6\u3082\u3059\u3079\u3066\u7814\u7a76\u306e\u4e2d\u306b\u7e54\u308a\u8fbc\u3080\u3079\u304d\u3067\u3042\u308b\u3002\u5897\u5206\u89e3\u6790\u3092\u6cbb\u7642\u4f01\u56f3\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u7528\u3044\u3066\u884c\u3044\u3001\u95a2\u9023\u3059\u308b\u4e9c\u7fa4\u89e3\u6790\u3082\u88dc\u8db3\u7684\u306b\u884c\u3046\u3079\u304d\u3067\u3042\u308b\u3002\u4e0d\u78ba\u5b9f\u6027\u306e\u7279\u5fb4\u3092\u660e\u3089\u304b\u306b\u3059\u3079\u304d\u3067\u3042\u308b\u3002\u8ad6\u6587\u306f\u78ba\u7acb\u3055\u308c\u3066\u3044\u308b\u8cbb\u7528\u5bfe\u52b9\u679c\u5206\u6790\u306e\u7d50\u679c\u5831\u544a\u306e\u30b9\u30bf\u30f3\u30c0\u30fc\u30c9\u3092\u9075\u5b88\u3059\u3079\u304d\u3067\u3042\u308b\u3002\u81e8\u5e8a\u8a66\u9a13\u306b\u4f34\u3046\u7d4c\u6e08\u306e\u7814\u7a76\u306f\u8cc7\u6e90\u914d\u5206\u306e\u6c7a\u5b9a\u3092\u3059\u308b\u969b\u306b\u81e8\u5e8a\u7684\u52b9\u679c\uff08Efficacy)\u3068\u4f34\u306b\u7d4c\u6e08\u7684\u4fa1\u5024\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u8003\u616e\u3059\u308b\u6c7a\u5b9a\u8005\u306e\u305f\u3081\u306e\u60c5\u5831\u3068\u3057\u3066\u3001\u4fa1\u5024\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u8003\u3048\u308b\u30e2\u30c7\u30eb\u5316\u7814\u7a76\u306e\u3088\u3046\u306a\u4ed6\u306e\u8a55\u4fa1\u3092\u88dc\u8db3\u3059\u308b\u3082\u306e\u3067\u3042\u308b\u3002 \u201d<\/p>\n\n\n\n

\u8cbb\u7528\u5bfe\u52b9\u679c\u5206\u6790\u306e\u7d50\u679c\u5831\u544a\u306e\u30b9\u30bf\u30f3\u30c0\u30fc\u30c9\u306fCHEERS<\/a>\u306e\u3053\u3068\u3002\u81e8\u5e8a\u8a66\u9a13\u3067\u6e2c\u5b9a\u3055\u308c\u308b\u30a2\u30a6\u30c8\u30ab\u30e0\u304c\u3088\u308a\u591a\u69d8\u5316\u3059\u308b\u3053\u3068\u306b\u306a\u308b\u306e\u3067\u306f\u306a\u3044\u304b\u3068\u8003\u3048\u3089\u308c\u308b\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u6642\u306b\u533b\u7642\u7d4c\u6e08\u7684\u5206\u6790\u3092\u81e8\u5e8a\u8a66\u9a13\u306b\u542b\u3081\u3066\u884c\u3046\u5834\u5408\u306e\u30ac\u30a4\u30c0\u30f3\u30b9\u304c International Society for Pharmacoeconomics and Outcomes Research (ISPOR)\u00a0 … “CEA alongside clinical trials II” \u306e<\/span>\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-320","post","type-post","status-publish","format-standard","hentry","category-cea"],"_links":{"self":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=320"}],"version-history":[{"count":6,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/320\/revisions"}],"predecessor-version":[{"id":400,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/320\/revisions\/400"}],"wp:attachment":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}